Actively Recruiting
Measuring Aided Language Development in Preschool Children with Speech and Language Disorders Using AAC Generative Language Intervention
Led by University of Central Florida · Updated on 2025-05-16
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Central Florida
Lead Sponsor
N
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the psychometric properties of various aided language measures based on the Graphic Symbol Utterance and Sentence Development Framework. The study aims to identify reliable tools that capture language growth in preschool children with speech and language disorders who use aided communication, assessing which contexts best reflect their language development. This research focuses on children with conditions such as Down Syndrome, Cerebral Palsy, and speech sound disorders during early stages of aided communication acquisition. Participants will receive an AAC Generative Language Intervention, a behavioral aided AAC language input/output therapy designed to support language acquisition. The study includes different phases: Aim 1A uses existing data from children who have had 4 months of intervention, while Aim 1B follows high-performing aided communicators receiving 24 months of intervention to monitor progress through all early acquisition stages. During the study, children will be assessed on aided language use, including measuring aided AAC utterance length over 24 months. Researchers will evaluate language growth through various elicitation contexts, using tools like iPad communication apps. Functional vision and hearing will be monitored to support study activities. The total participation period extends over two years, with ongoing assessments to establish reliable and clinically useful language measures.
CONDITIONS
Brief Title
Measuring Aided Language Development
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of Down Syndrome or Cerebral Palsy with significant speech impairment
- English as the primary language
- Ability to express at least 25 words using any communication mode
- Ability to select picture symbols on iPad communication app with at least 50% accuracy
- Vision and hearing within functional limits or corrected for study activities
You will not qualify if you...
- Clinical diagnosis of Autism or Social Communication Disorder
- Primary language spoken is not English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 24 months
Participants receive AAC Generative Language Intervention to support aided language development.
Visits scheduled according to intervention protocol
Trial Site Locations
Total: 1 location
1
University of Central Florida - Innovative Center
Orlando, Florida, United States, 32826
Actively Recruiting
Research Team
J
Jennifer Kent-Walsh, PhD
C
Cathy Binger, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here